Inhibition of cellular respiration by doxorubicin

Chemical Research in Toxicology

Volumn 19, Issue 8, 2006, Pages 1051-1058

  Tao, Zhimin ^a   Withers, Henry G ^b   Penefsky, Harvey S ^c   Goodisman, Jerry ^a   Souid, Abdul Kader ^b  

^a SYRACUSE UNIVERSITY   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE PERMEABILITY; CELL RESPIRATION; CONCENTRATION RESPONSE; DNA STRAND BREAKAGE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL TOXICITY; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; RESPIRATORY CHAIN;

ADENOSINE TRIPHOSPHATE; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; DNA TOPOISOMERASES, TYPE II; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; HELA CELLS; HUMANS; JURKAT CELLS; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION;

EID: 33748675288     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx050315y     Document Type: Article

References (25)

1. Binaschi, M., Bigioni, M., Cipollone, A., Rossi, C., Goso, C., Maggi, C. A., Capranico, G., and Animati, F. (2001) Anthracyclines: Selected new developments. Curr. Med. Chem. 1, 113-130.
2. Zunino, F., and Capranico, G. (1990) DNA topoisomerase II as the primary target of antitumor anthracyclines. Anticancer Drug Des. 5, 307-317.
3. Nitiss, J. L. (2002) DNA topoisomerases in cancer chemotherapy: Using enzymes to generate selective DNA damage. Curr. Opin. Invest. Drugs 3, 1512-1516.
4. Doroshow, J. H. (1983) Effect of anthracyclines antibiotics on oxygen radical formation in rat heart. Cancer Res. 43, 460-472.
5. Davis, K. J., and Doroshow, J. H. (1986) Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J. Biol. Chem. 261, 3060-3067.
6. Doroshow, J. H., and Davis, K. J. (1986) Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide and hydroxyl radical. J. Biol. Chem. 261, 3068-3074.
7. Huigsloot, M., Tijdens, I. B., Mulder, G. J., and van de Water, B. (2002) Differential regulation of doxorubicin-induced mitochondrial dysfunction and apoptosis by Bcl-2 in mammary adenocarcinoma (MTLn3) cells. J. Biol. Chem. 277, 35869-35879.
8. Kostoryz, E. L., and Yourtee, D. M. (2001) Oxidative mutagenesis of doxorubicin-Fe(III) complex. Mutat. Res. 490, 131-139.
9. Bellarosa, D., Ciucci, A., Bullo, A., Nardelli, F., Manzini, S., Maggi, C. A., and Goso, C. (2001) Apoptotic events in a human ovarian cancer cell line exposed to anthracyclines. J. Pharmacol. Exp. Ther. 296, 276-283.
10. Lorenzo, E., Ruiz-Ruiz, C., Quesada, A. J., Hernandez, G., Rodriguez, A., Lopez-Rivas, A., and Redondo, J. M. (2002) Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism. J. Biol. Chem. 277, 10883-10892.
11. Green, D. R., and Kroemer, G. (2004) The pathophysiology of mitochondrial cell death. Science 305, 626-629.
12. Batandier, C., Leverve, X., and Fontainer, E. (2004) Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex I. J. Biol. Chem. 279, 17197-17204.
13. Speth, P. A., Linssen, P. C., Boezeman, J. B., Wessels, H. M., and Haanen, C. (1987) Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients. Cancer Chemother. Pharmacol. 20, 305-310.
14. Lemasters, J. J., and Hackenbrock, C. R. (1979) Continuous measurements of adenosine triphosphate with firefly luciferase luminescence. Methods Enzymol. 56, 530-544.
15. Harker, W. G., Slade, D. L., Drake, F. H., and Parr, R. L. (1991) Mitoxantrone resistance in HL-60 leukemia cells: Reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase II β isoform. Biochemistry 30, 9953-9961.
16. Lo, L.-W., Koch, C. J., and Wilson, D. F. (1996) Calibration of oxygen-dependent quenching of the phosphorescence of Pd-meso-tetra (4-carboxyphenyl) porphine: A phosphor with general application for measuring oxygen concentration in biological systems. Anal. Biochem. 236, 153-160.
17. Souid, A.-K., Tacka, K. A., Galvan, K. A., and Penefsky, H. S. (2003) Immediate effects of anticancer drugs on mitochondrial oxygen consumption. Biochem. Pharmacol. 66, 977-987.
18. Tacka, K. A., Dabrowiak, J. C., Goodisman, J., Penefsky, H. S., and Souid, A.-K. (2004) Quantitative studies on cisplatin-induced cell death. Chem. Res. Toxicol. 17, 1102-1111.
19. Tacka, K. A., Szalda, D., Souid, A.-K., Goodisman, J., Dabrowiak, J. C. (2004) Experimental and theoretical studies on the pharmacodynamics of cisplatin in Jurkat cells. Chem. Res. Toxicol. 17, 1434-1444.
20. Karamohamed, S., and Guidotti, G. (2001) Bioluminometric method for real-time detection of ATPase activity. BioTechniques 31, 420-425.
21. Slee, E. A., Zhu, H., Chow, S. C., MacFarlane, M., Nicholson, D. W., and Cohen, G. M. (1996) Benzylooxycarbonyl-Val-Ala-Asp (Ome) fluormethyl ketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315, 21-24.
22. Finucane, D. M., Waterhouse, N. J., Amarante-Mendes, G. P., Cotter, T. G., and Green, D. R. (1999) Collapse of inner mitochondrial transmembrane potential is not required for apoptosis of HL60 cells. Exp. Cell Res. 251, 166-174.
23. Waterhouse, N. J., Goldstein, J. C., von Ahsen, O., Schuller, M., Newmeyer, D. D., and Green, D. R. (1999) Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J. Cell Biol. 153, 319-328.
24. Ricci, J.-E., Gottlieb, R. A., and Green, D. R. (2003) Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J. Cell Biol. 160, 65-75.
25. Mizutani, H., Tada-Oikawa, S., Hiraku, Y., Kojima, M., and Kawanishi, S. (2005) Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci. 76, 1439-1453.